Use of anti-craving agents in soldiers with alcohol dependence syndrome

Medical Journal Armed Forces India

Volumn 64, Issue 4, 2008, Pages 320-324

  Narayama, P L ^a   Gupta, A K ^b   Sharma, P K ^c  

^a AFCME   (India)

^b Department of Pyschiatry   (India)

^c 5 Air Force Hospital   (India)

Author keywords

Acamprosate; Alcohol dependence syndrome; Naltrexone; Topiramate

Indexed keywords

ACAMPROSATE; NALTREXONE; TOPIRAMATE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; FATIGUE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORNING DOSAGE; NAUSEA; NERVOUSNESS; OCCUPATIONAL HEALTH; PRURITUS; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SOLDIER; TREATMENT DURATION; VOMITING; WEIGHT REDUCTION;

EID: 57349117984     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0377-1237(08)80009-3     Document Type: Article

References (22)

1. Raju MSVK, Valdiya PS, Tampi UR, et al. Alcoholism in the Armed Forces. MJAFI 2002;58:149-51.
2. Golechha GR, Sethi IC, Deshpande PL, Agnihotra U. The treatment of alcoholism. Indian J Psychiatry 1991;33:44-7.
3. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, et al. Oral Topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 2003;361:1677-85.
4. Swift RM. Topiramate for the treatment of alcohol dependence: initiating abstinence. Lancet 2003;361:1666-7.
5. Komanduri R. Two cases of alcohol craving curbed by Topiramate. J Clin Psychiatry 2003; 64:612.
6. Anderson N, Oliver MN. Oral Topiramate effective for alcoholism. J Fam Pract 2003;52:682- 7.
7. Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F. Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004;37:37-40.
8. Johnson BA. Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Alcohol Clin Exp Res 2004;28:1137-44.
9. Johnson BA. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opin Pharmacother 2004;5:1943-55.
10. Johnson BA, Akhtar FZ, Ait-Daoud N, Ma JZ. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 2004;61:905-12.
11. Myrick H, Anton R. Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep 2004;6:332-8.
12. Kenna GA, McGeary JE, Swift RM. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Am J Health Syst Pharm 2004;61:2272-9.
13. Addolorato G, Johnson BA, Swift RM, Ciraulo DA, Myrick H. Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res 2005;29:248-54.
14. Rubio G, Manzanares J, Lopez-Munoz F, et al. Naltrexone improves outcome of a controlled drinking program. J Subst Abuse Treat 2002;23:361-6.
15. Drobes DJ, Anton RF, Thomas SE, Voronin K. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: Naltrexone and Nalmefene. Neuro Psycho- pharmacology 2003;28:755-64.
16. O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG. Initial and maintenance Naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. Arch Intern Med 2003;163:1695-704.
17. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, et al. Comparing and combining Naltrexone and Acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2003;60:92-9.
18. Gastpar M, Bonnet U, Boning J, Mann K, Schmidt LG, Soyka M, et al. Lack of efficacy of Naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol. 2002;22:592-8.
19. Jung YC, Namkoong K. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. Yonsei Med J. 2006;47:167-78.
20. Chawla PS, Kochar MS. What's new in clinical pharmacology and therapeutics. Wis Med J 2006;105:24-9.
21. Mason BJ. Acamprosate and Naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. Eur Neuropsychopharmacol 2003; 13:469-75.
22. Mason BJ. Treatment of alcohol-dependent out patients with Acamprosate: a clinical review. J Clin Psychiatry 2001;62 Suppl 20:42-8.